Company profile for Aura Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Aura Biosciences, we are developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach we call molecular surgery. By safely eliminating cancer locally, we can treat early and transform the lives of people with a wide range of cancers that are poorly managed today. Our lead program in ocular melanoma (OM), also known as choroidal or uveal melanom...
At Aura Biosciences, we are developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach we call molecular surgery. By safely eliminating cancer locally, we can treat early and transform the lives of people with a wide range of cancers that are poorly managed today. Our lead program in ocular melanoma (OM), also known as choroidal or uveal melanoma, is designed to remove cancer cells in the back of the eye as a first-line therapy, while allowing for the potential of preserving patients’ vision.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
85 Bolton Street Cambridge, MA 02140
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

CGT Asia

Not Confirmed

envelop Contact Supplier

CGT Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/03/30/3264473/0/en/Aura-Biosciences-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Business-Highlights.html

GLOBENEWSWIRE
30 Mar 2026

https://www.globenewswire.com/news-release/2026/02/25/3244460/0/en/Aura-Biosciences-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
25 Feb 2026

https://www.globenewswire.com/news-release/2025/11/24/3193929/0/en/Aura-Biosciences-to-Participate-in-the-8th-Annual-Evercore-Healthcare-Conference.html

GLOBENEWSWIRE
24 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187148/0/en/Aura-Biosciences-Reports-Third-Quarter-2025-Financial-Results-and-Business-Highlights.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/09/03/3143425/0/en/Aura-Biosciences-to-Participate-in-the-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html

GLOBENEWSWIRE
03 Sep 2025

https://www.globenewswire.com/news-release/2025/08/13/3132426/0/en/Aura-Biosciences-Reports-Second-Quarter-2025-Financial-Results-and-Business-Highlights.html

GLOBENEWSWIRE
13 Aug 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty